   Section 1134, Pub. L. 92–255, title II, § 224, Mar. 21, 1972, 86 Stat. 71, provided for establishment of research and development programs by Director.
   Section 1135, Pub. L. 92–255, title II, § 225, Mar. 21, 1972, 86 Stat. 72, provided for establishment of a single non-Federal share requirement.
   Section 1136, Pub. L. 92–255, title II, § 226, Mar. 21, 1972, 86 Stat. 72, provided for Director to make drug prevention function recommendations to President and to consult with responsible agencies with respect to drug prevention functions.
   Section 1137, Pub. L. 92–255, title II, § 227, Mar. 21, 1972, 86 Stat. 72, provided for resolution of agency conflicts with regard to drug prevention functions.
   Section 1138, Pub. L. 92–255, title II, § 228, Mar. 21, 1972, 86 Stat. 72, provided for communications and liaison with respect to drug prevention functions by one of Assistant Directors.
   Section 1139, Pub. L. 92–255, title II, § 229, Mar. 21, 1972, 86 Stat. 72, provided, with respect to drug prevention functions, coordination of State and local governments, availability of information and other services and activities.
   Section 1140, Pub. L. 92–255, title II, § 230, Mar. 21, 1972, 86 Stat. 73, provided for a management oversight review by a Federal officer.
   Section 1141, Pub. L. 92–255, title II, § 231, Mar. 21, 1972, 86 Stat. 73, provided for convening of a council of officials of Federal agencies responsible for drug prevention functions by Director.
   Section 1142, Pub. L. 92–255, title II, § 232, Mar. 21, 1972, 86 Stat. 73, provided for designation of the Director to represent Government in international negotiations related to drug prevention functions.
   Section 1143, Pub. L. 92–255, title II, § 233, Mar. 21, 1972, 86 Stat. 73, provided for an annual written report to the President by the Director.
